Modeling the acute pharmacological response to selective serotonin reuptake inhibitors in human brain using simultaneous PET/MR imaging

[1]  Siegfried Kasper,et al.  Reduced task durations in functional PET imaging with [18F]FDG approaching that of functional MRI , 2018, NeuroImage.

[2]  L. Reneman,et al.  Serotonin transporter occupancy by the SSRI citalopram predicts default-mode network connectivity , 2018, European Neuropsychopharmacology.

[3]  Siegfried Kasper,et al.  Spatial analysis and high resolution mapping of the human whole-brain transcriptome for integrative analysis in neuroimaging , 2018, NeuroImage.

[4]  J. Dukart,et al.  Test-retest reliability of task-based and resting-state blood oxygen level dependence and cerebral blood flow measures , 2018, bioRxiv.

[5]  Nicolas Costes,et al.  In vivo biased agonism at 5-HT1A receptors: characterisation by simultaneous PET/MR imaging , 2018, Neuropsychopharmacology.

[6]  Christopher H. Chatham,et al.  Cerebral blood flow predicts differential neurotransmitter activity , 2017, bioRxiv.

[7]  B. Rosen,et al.  Functional Characterization of 5-HT1B Receptor Drugs in Nonhuman Primates Using Simultaneous PET-MR , 2017, The Journal of Neuroscience.

[8]  Lucas Rischka,et al.  Simple and rapid quantification of serotonin transporter binding using [11C]DASB bolus plus constant infusion , 2017, NeuroImage.

[9]  Alan C. Evans,et al.  Biomarkers, designs, and interpretations of resting‐state fMRI in translational pharmacological research: A review of state‐of‐the‐Art, challenges, and opportunities for studying brain chemistry , 2017, Human brain mapping.

[10]  Christian Windischberger,et al.  Imaging the neuroplastic effects of ketamine with VBM and the necessity of placebo control , 2017, NeuroImage.

[11]  G. Kranz,et al.  Ketamine-dependent neuronal activation in healthy volunteers , 2016, Brain Structure and Function.

[12]  N. Costes,et al.  Selective serotonin 5-HT1A receptor biased agonists elicitdistinct brain activation patterns: a pharmacoMRI study , 2016, Scientific Reports.

[13]  Christian Windischberger,et al.  (S)-citalopram influences amygdala modulation in healthy subjects: a randomized placebo-controlled double-blind fMRI study using dynamic causal modeling , 2015, NeuroImage.

[14]  H. Möller,et al.  World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders. Part 2: Maintenance Treatment of Major Depressive Disorder-Update 2015 , 2015, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[15]  Serge A. R. B. Rombouts,et al.  Single-dose serotonergic stimulation shows widespread effects on functional brain connectivity , 2014, NeuroImage.

[16]  D. Margulies,et al.  Serotonergic Modulation of Intrinsic Functional Connectivity , 2014, Current Biology.

[17]  Bruce R. Rosen,et al.  A receptor-based model for dopamine-induced fMRI signal , 2013, NeuroImage.

[18]  Aart J. Nederveen,et al.  Mapping the hemodynamic response in human subjects to a dopaminergic challenge with dextroamphetamine using ASL-based pharmacological MRI , 2013, NeuroImage.

[19]  David Borsook,et al.  Parallel Buprenorphine phMRI Responses in Conscious Rodents and Healthy Human Subjects , 2013, The Journal of Pharmacology and Experimental Therapeutics.

[20]  Aart J. Nederveen,et al.  Feasibility of ASL-based phMRI with a single dose of oral citalopram for repeated assessment of serotonin function , 2012, NeuroImage.

[21]  U. Heinemann,et al.  Fluoxetine induces vasodilatation of cerebral arterioles by co-modulating NO/muscarinic signalling , 2012, Journal of cellular and molecular medicine.

[22]  J. Booij,et al.  Mapping serotonergic dysfunction in MDMA (ecstasy) users using pharmacological MRI , 2012, European Neuropsychopharmacology.

[23]  Shane McKie,et al.  Differential Effects of Anaesthesia on the phMRI Response to Acute Ketamine Challenge. , 2012, British journal of medicine and medical research.

[24]  Francesco de Pasquale,et al.  Differential response to specific 5-Ht(7) versus whole-serotonergic drugs in rat forebrains: A phMRI study , 2011, NeuroImage.

[25]  R Dudczak,et al.  Simple and rapid preparation of [11C]DASB with high quality and reliability for routine applications. , 2009, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[26]  G. Glover,et al.  Methods and Software for fMRI Analysis of Clinical Subjects , 2009, NeuroImage.

[27]  Shane McKie,et al.  Glutamate and the neural basis of the subjective effects of ketamine: a pharmaco-magnetic resonance imaging study. , 2008, Archives of general psychiatry.

[28]  C. Bundgaard,et al.  An integrated microdialysis rat model for multiple pharmacokinetic/pharmacodynamic investigations of serotonergic agents. , 2007, Journal of pharmacological and toxicological methods.

[29]  Angelo Bifone,et al.  Study-level wavelet cluster analysis and data-driven signal models in pharmacological MRI , 2007, Journal of Neuroscience Methods.

[30]  D. Townsend,et al.  Method for transforming CT images for attenuation correction in PET/CT imaging. , 2006, Medical physics.

[31]  F. Larsen,et al.  The Pharmacokinetics of Escitalopram After Oral and Intravenous Administration of Single and Multiple Doses to Healthy Subjects , 2005, Journal of clinical pharmacology.

[32]  R. Elliott,et al.  Neuronal effects of acute citalopram detected by pharmacoMRI , 2005, Psychopharmacology.

[33]  Bengt Långström,et al.  Potential of [11C]DASB for measuring endogenous serotonin with PET: binding studies. , 2005, Nuclear medicine and biology.

[34]  Sylvain Houle,et al.  Regional distribution of serotonin transporter protein in postmortem human brain: is the cerebellum a SERT-free brain region? , 2005, Nuclear medicine and biology.

[35]  Sylvain Houle,et al.  Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study. , 2004, The American journal of psychiatry.

[36]  N. Tzourio-Mazoyer,et al.  Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain , 2002, NeuroImage.

[37]  Alan A. Wilson,et al.  Positron Emission Tomography Quantification of [11C]-DASB Binding to the Human Serotonin Transporter: Modeling Strategies , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[38]  R. Turner,et al.  Characterization and Correction of Interpolation Effects in the Realignment of fMRI Time Series , 2000, NeuroImage.

[39]  F. Artigas,et al.  Modulation of the Extracellular 5-Hydroxytryptamine Brain Concentrations by the Serotonin and Noradrenaline Reuptake Inhibitor, Milnacipran Microdialysis Studies in Rats , 1999, Neuropsychopharmacology.

[40]  Roberto Invernizzi,et al.  Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortex , 1992, Brain Research.